| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.01 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.087 | 0.03 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.03 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.086 | 0.03 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.03 |